Article Text

PDF
Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma
  1. Carmen Rosaria Gigliotti1,
  2. Giulio Modorati2,
  3. Maura Di Nicola2,
  4. Claudio Fiorino1,
  5. Lucia Alessia Perna1,
  6. Elisabetta Miserocchi2,
  7. Alberto Franzin3,
  8. Piero Picozzi3,
  9. Angelo Bolognesi4,
  10. Pietro Mortini3,
  11. Antonella del Vecchio1,
  12. Riccardo Calandrino1
  1. 1Department of Medical Physics, San Raffaele Scientific Institute, Milano, Italy
  2. 2Department of Ophthalmology, San Raffaele Scientific Institute, Milano, Italy
  3. 3Department of Neurosurgery, San Raffaele Scientific Institute, Milano, Italy
  4. 4Department of Radiotherapy, San Raffaele Scientific Institute, Milano, Italy
  1. Correspondence to Dr Antonella del Vecchio, Department of Medical Physics, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy; delvecchio.antonella{at}hsr.it

Abstract

Aims The aim of the present work is to assess the main predictors of the most clinically relevant radio-induced effects after Gamma Knife stereotactic radiosurgery (GKRS) for uveal melanoma (UM).

Materials and methods Medical records and three-dimensional dosimetry data of critical structures of 66 patients were retrospectively reviewed. Cox’s proportional hazard model was used to identify clinical and dosimetric variables as independent risk factor for GKRS-related complications.

Results The fraction of the posterior segment receiving more than 20Gy (V20), Bruch’s membrane rupture and tumour thickness were significant prognostic factors for neovascular glaucoma. A clear relationship with the dose received by 1% of the optic nerve (D1%) was found for radiation retinopathy and papillopathy. Multivariables models resulted for visual acuity (VA) reduction >20% of the basal value and for complete VA loss, both including largest tumour diameter and D1% to the optic nerve. The predictive model for complete VA loss includes also Bruch’s membrane rupture. An alternative model for complete visual acuity loss, including the optic nerve-prescription isodose minimum distance, was also suggested.

Conclusions We found clinical and dosimetric variables to clearly predict the risk of the main side effects after GKRS for UM. These results may provide dose constraints to critical structures, potentially able to reduce side effects. Constraining D1% to the optic nerve below 12-13Gy may result in a dramatic reduction of blindness risk, while reducing V20 of the posterior segment of the bulb could limit the neovascular glaucoma onset.

  • Neoplasia
  • Visual Pathway
  • Treatment Other

Statistics from Altmetric.com

Footnotes

  • Contributors CR, dVA and MG conceived of the study. MG, ME, DNM, FA, PP, BA and MP initiated the study design including patient recruitment and clinical data collection. GCR, dVA and PLA conducted the dosimetric study including data collection and statistical analysis. FC provided statistical expertise in clinical trial design and GCR is conducting the primary statistical analysis. GCR prepared the manuscript draft. All authors contributed to refinement of the study protocol and approved the final manuscript.

  • Competing interests The corresponding author AdV has a contract as starter-up with Elekta Instrument AB. No other conflict of interests to declare for the other authors.

  • Patient consent Obtained.

  • Ethics approval IRCCS Ospedale San Raffaele Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.